Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHair thinning is one of the more distressing things women report during weight loss on Wegovy, and questions about it come up frequently. It is real, it is recognised, and it is almost always temporary. Most cases are driven by the physical stress of rapid weight change rather than semaglutide acting directly on hair follicles — a distinction that matters for understanding what to expect. Wegovy (semaglutide) is a prescription-only medicine; a clinician reviews whether it is suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The link between Wegovy and hair loss in women is not straightforward, and separating cause from coincidence helps. Semaglutide suppresses appetite substantially, that is its therapeutic effect. When calorie intake drops fast and body weight falls quickly, the body reads this as physiological stress. In response, a larger proportion of hair follicles shift from their active growing phase (anagen) into a resting phase (telogen), then shed together around two to four months later. This pattern is called telogen effluvium.
It is the same mechanism that causes hair loss after surgery, illness, or any period of significant nutritional restriction. There is currently no robust clinical evidence that semaglutide damages follicles directly. The NHS medicines page for semaglutide lists hair loss among reported side effects, and the prescribing information acknowledges it, but the biological driver is predominantly the rate and scale of weight loss rather than the molecule itself.
Women can be more prone to this pattern than men, partly because of hormonal factors and because pre-existing low ferritin or iron stores are common and can tip a follicle already under stress toward shedding. If you want a broader picture of how Wegovy affects women specifically, our page on Wegovy side effects in women covers the wider profile.
For most women, the shedding peaks somewhere between three and six months after weight loss accelerates, then tapers off. This timing often surprises people, by the point hair comes out in larger handfuls, the acute weight loss phase may already be moderating, so the connection feels confusing. Once the body settles at a new weight and nutrition is maintained, follicles cycle back into the growing phase and regrowth tends to follow.
Full recovery usually takes six to twelve months from the point shedding peaks, though this varies. A few factors can extend the timeline: ongoing nutritional gaps, very rapid continued weight loss, or underlying conditions such as thyroid dysfunction that happen to coexist. If hair loss is still worsening after six months or is accompanied by other symptoms (fatigue, cold sensitivity, changes in skin or nails) that warrants a GP appointment to rule out an independent cause rather than attributing everything to treatment.
Our detailed page on hair loss from Wegovy covers what recovery typically looks like and what supports regrowth, including protein targets and the evidence around supplementation.
The single most protective factor is adequate protein. When overall calorie intake is reduced on semaglutide, it is easy to let protein slip below the level hair follicles need. Most clinical guidance points to a minimum of around 1.2 g per kilogram of body weight per day during active weight loss, though your prescriber or a dietitian is best placed to set a personal figure. Iron levels are worth checking, particularly for women who menstruate, since ferritin can be low even when a standard blood count looks normal.
Practically, this means prioritising protein at every meal even when appetite is poor, and being deliberate about iron-rich foods or supplements if a GP confirms deficiency. Biotin supplements are widely marketed for hair loss, but the evidence behind them specifically for telogen effluvium is thin; they are unlikely to harm, but should not replace addressing real nutritional gaps.
Gentle hair care (avoiding tight styles, heat, and aggressive brushing on wet hair) reduces mechanical breakage on top of any shedding. These are small adjustments, but they add up over a six-month window. Our broader guide to Wegovy side effects has more on managing the GI symptoms that sometimes make eating enough protein harder in the early weeks of treatment.
Mild shedding during active weight loss rarely needs urgent attention, but some patterns do. Get a GP or dermatology appointment if: shedding is severe and sustained beyond six months; you notice patchy loss rather than diffuse thinning across the scalp; loss is accompanied by symptoms that suggest thyroid or autoimmune involvement; or hair loss began before significant weight change and may therefore have a different cause altogether.
If you suspect a side effect from Wegovy specifically, the UK's Yellow Card scheme lets you report it directly to the MHRA at yellowcard.mhra.gov.uk, patients can submit reports, not just clinicians. This reporting genuinely contributes to post-marketing safety monitoring for newer medicines.
If you are weighing up how hair loss concerns sit alongside your overall reasons for considering treatment, that conversation belongs in a clinical consultation. At nume, a GPhC-registered prescriber reads every consultation personally and discusses side effects as part of assessing suitability, never a form routed to an algorithm. You can speak to our prescribers about whether Wegovy is appropriate for you. If you would like to read more, our page on Wegovy hair loss explores the topic in detail, and we have a separate resource looking at Wegovy side effects and hair loss together for those who want to understand how this fits into the broader side effect picture. We also have a dedicated page on whether Wegovy causes hair loss in women if you want a more direct answer to that specific question.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.